ASXCorporate Governance Statement 2026
other announcement
MVP
Medical Developments International
Pharmaceuticals, Biotechnology & Life Sciences
Medical Developments International (MVP) is a pharmaceutical company focused on developing and distributing innovative medical devices. They operate in the acute pain and respiratory illness treatment sectors, aiming to improve patient care globally. MDI partners with organizations like CSIRO to drive industry-leading product development.
Short position
short percentage0.00%
reported shorts152
shares on issue112.658M
Medical Developments International (ASX:MVP) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 152 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 3.86% in September 2021. MVP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Medical Developments International (MVP) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Notice of Annual General Meeting 2026
other announcement
Cat at centre of concussion waiver saga forced into medical retirement
Geelong premiership defender Jake Kolodjashnij, who was at the centre of the club's concussion waiver scandal, has medically retired.
Notification of cessation of securities - MVP
other announcement
Date of AGM and Closing Date for Director Nominations
other announcement
SA Health employee reprimanded for accessing Tony Modra's medical records
A SA Health employee has been reprimanded for snooping on AFL legend Tony Modra's private medical records after he was seriously injured in a truck crash, while two other workers remain under investigation, the health department says.
Motley FoolImricor Medical Systems and Philips launch MR-guided cardiac interventions lab
Imricor Medical Systems has teamed up with Philips to launch a new MR-guided cardiac interventions lab, targeting broader clinical adoption. The post Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab appeared first on The Motley Fool Australia.
Small CapsStorm enforcer Kamikamica forced into medical retirement after stroke
Tui Kamikamica's 142-game NRL career comes to an end after he received fresh medical advice following a stroke earlier in the year.
KalkineAvita Medical Allocates 7,260 Restricted US Stock Units to Key Executives
Avita Medical Inc. (ASX:AVH) announced the issuance of 7,260 Restricted US Stock Units (security code: AVHAAA) to key management personnel. These securities were granted on 26 May 2026, with the official notification submitted to the ASX on 12 August 2026. Key Highlights 7,260 Restricted US Stock Units (AVHAAA) were granted on 26 May 2026 as part of an employee incentive plan The units were allocated to key management personnel or their associates The filing was delayed due to an administrati...
Why James Hardie, Avita Medical and ResMed shares are turning heads on Friday
Why is everyone talking about Avita Medical, ResMed, and James Hardie shares today? The post Why James Hardie, Avita Medical and ResMed shares are turning heads on Friday appeared first on The Motley Fool Australia.
Tony Modra medical record probe expands to extra staffer
Another staff member is being investigated for allegedly inappropriately accessing the private medical records of AFL legend Tony Modra, SA Health says.
Why DMedical (ASX:DX) Leads AI Healthcare Imaging?
Highlights Artificial Intelligence Stocks remains in focus as artificial intelligence adoption and operational delivery continue shaping sector attention. Data quality, software capability and commercial execution remain central considerations as Australian companies respond to evolving market conditions. Balance sheet management, strategic discipline and consistent execution continue influencing the broader business outlook. Australia's artificial intelligence stocks landscape remains closel...
IMEXHS Limited Shifts Registered Office to North Sydney to Boost Medical Imaging Operations
Effective July 27, 2026, IMEXHS Limited has officially relocated its registered office to North Sydney. This strategic relocation supports the company’s expansion in the medical imaging software industry, where it operates across 18 countries including Australia and the United States. Stakeholders will be closely observing how this move enhances IMEXHS’s operational efficiency and market positioning. Key Points IMEXHS Limited (IME) New registered office address: Suite 201, Level 2, 5 Blue...
Google NewsWhy Did Medical Developments Shares Jump 26.28%? Here's What Investors Are Watching About ASX:MVP - Kalkine
Why Did Medical Developments Shares Jump 26.28%? Here's What Investors Are Watching About ASX:MVP Kalkine
Modra's medical records allegedly inappropriately accessed by SA Health staff
Three SA Health staff are being investigated for alleged inappropriate access to the private medical records of AFL star Tony Modra, while a further five are being "assessed" to determine whether their access to the records was appropriate.
Appendix 4C and Quarterly Activity Report 30 June 2026
other announcement
StockheadHealth Check: Medical pot providers need better regulation, says medical pot provider
ECS Botanics is enjoying a profitability purple patch, but endorses moves to tighten regulation of the local medical cannabis sector. ... Read More The post Health Check: Medical pot providers need better regulation, says medical pot provider appeared first on Stockhead.
Medical tech firm Ceretas fast tracks IPO to fund clinical trials
The listing date was scheduled for July 28, but Laws says the owners are seeking to debut sooner, “aiming for the back end of next week if possible”.
Imricor Medical Shares Surge on Fresh FDA Clearance
Highlights Imricor Medical Systems (ASX:IMR) shares surged after receiving an additional US Food and Drug Administration (FDA) clearance for its MRI-compatible cardiac catheter technology. The latest approval expands the device's use to include paediatric patients, broadening its addressable hospital market in the United States. Regulatory milestones continue to act as major catalysts for smaller ASX-listed medical technology companies. Shares in Imricor Medical Syst...
Why Medical Developments International (ASX:MVP) Shares Are Under Pressure Today - Kalkine
Why Medical Developments International (ASX:MVP) Shares Are Under Pressure Today Kalkine
AI Stocks To Watch With Real Exposure To Chips Software And Medical AI - simplywall.st
AI Stocks To Watch With Real Exposure To Chips Software And Medical AI simplywall.st
Medical Developments (ASX:MVP) Surges 35% After Penthrox Drives Positive Cash Flow and European Expansion - Stocks Down Under
Medical Developments (ASX:MVP) Surges 35% After Penthrox Drives Positive Cash Flow and European Expansion Stocks Down Under
Why Is (ASX:MVP) Gaining Attention as Penthrox Strengthens Cash Flow?
Highlights Strong demand lifts flagship pain product Cash flow turns positive amid steady expansion Europe remains a key focus for upcoming approvals Medical Developments International is witnessing stronger commercial traction, supported by its flagship product and improving financial stability, while regulatory progress in Europe continues to shape its near-term outlook. A Turning Point for Medical Developments International Medical Developments International (ASX:MVP) has delivered a...
Appendix 4C and Quarterly Activity Report 31 March 2026
other announcement
Health Check: US report ponders the dark side of dollar-driven medical AI
AI is pitched as a way to improve and expedite patient treatment and create clinical efficiencies. But is it really ... Read More The post Health Check: US report ponders the dark side of dollar-driven medical AI appeared first on Stockhead.
Appendix 4C and Quarterly Activity Report 31 December 2025
other announcement
Change of Director's Interest Notice - R Basser
director_dealing announcement
2025 Annual General Meeting Chair and CEO addresses
other announcement
Appendix 4C and Quarterly Activity Report 30 September2025
other announcement
Change of Director's Interest Notice - M Fladrich
director_dealing announcement
Change of Director's Interest Notice - P Townsend
director_dealing announcement